Physician profile
Ashley A Ferrell
NPI 1386215085
$1,403.32
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $432 · 2022: $971.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $580.00 | 2021-2022 | |
| Amgen INC. | $226.77 | 2021-2022 | |
| Ucb, INC. | $180.94 | 2021-2022 | |
| Janssen Biotech, INC. | $171.41 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $61.44 | 2021-2022 | |
| Horizon Therapeutics Plc | $61.04 | 2022 | |
| Emmaus Medical, INC. | $38.34 | 2021 | |
| Lilly USA, LLC | $20.91 | 2021 | |
| Daiichi Sankyo INC. | $19.01 | 2022 | |
| Aurinia Pharma U.S., INC. | $14.93 | 2022 | |
| Bioventus LLC | $14.58 | 2022 | |
| Kaleo, INC. | $13.95 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Ferrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.